Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $77,161,000 | $89,210,000 | $584,780 | $582,485 |
| Short-Term Investments | $0 | $0 | $17,011 | $15,493 |
| Receivables | $47,129,000 | $44,744,000 | $39,686,000 | $33,310,000 |
| Inventory | $61,580,000 | $46,657,000 | $41,062,000 | $275,424 |
| Other Curr. Assets | $32,009,000 | $34,148,000 | -$159,267,018 | -$32,833,629 |
| Total Curr. Assets | $217,879,000 | $214,759,000 | $1,431,982 | $1,349,774 |
| Property Plant & Equip (Net) | $90,451,000 | $68,607,000 | $498,152 | $516,222 |
| Goodwill | $47,494,000 | $2,285,000 | $2,564,000 | $2,954,000 |
| Intangibles | $8,575,000 | $6,932,000 | $6,997,000 | $6,587,000 |
| Long-Term Investments | $0 | $0 | $253,186 | $231,104 |
| Tax Assets | $3,975,000 | $3,869,000 | $40,428 | $43,515 |
| Other NC Assets | $53,497,000 | $49,721,000 | -$9,453,808 | -$9,425,555 |
| Total NC Assets | $203,992,000 | $131,414,000 | $898,957 | $906,287 |
| Other Assets | $4,000 | $2,000 | $0 | $0 |
| Total Assets | $421,875,000 | $346,175,000 | $2,330,939 | $2,258,106 |
| Liabilities | – | – | – | – |
| Payables | $19,050,000 | $16,991,000 | $16,025,000 | $13,660,000 |
| Short-Term Debt | $7,035,000 | $5,304,000 | $4,177,000 | $8,033,000 |
| Tax Payable | $6,963,000 | $6,643,000 | $37,996 | $25,105 |
| Deferred Revenue | $0 | $0 | $0 | $25,105 |
| Other Curr. Liab. | $61,560,000 | $58,149,000 | -$19,636,617 | -$21,155,936 |
| Total Curr. Liab. | $94,608,000 | $87,087,000 | $603,379 | $587,274 |
| LT Debt | $43,188,000 | $5,190,000 | $7,516,000 | $13,350,000 |
| Deferred Rev, NC | $0 | $2,585,000 | $8,912 | $1,470 |
| Deferred Tax Liab, NC | $2,081,000 | $1,597,000 | $1,173,000 | $1,537,000 |
| Other NC Liab. | $10,560,000 | $2,683,000 | $5,750,000 | $4,509,000 |
| Total NC Liab. | $55,829,000 | $12,055,000 | $108,645 | $158,582 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $150,437,000 | $99,142,000 | $712,024 | $746,571 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6,504,000 | $6,504,000 | $6,504,000 | $53,430 |
| Retained Earnings | $228,442,000 | $209,399,000 | $184,005,000 | $1,332,432 |
| AOCI | $0 | $0 | $140,793 | $71,758 |
| Other Equity | $25,147,000 | $30,420,000 | $19,059,000 | $7,024 |
| Total Equity | $260,093,000 | $246,323,000 | $1,577,433 | $1,465,556 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $11,345,000 | $710,000 | $41,459 | $45,955 |
| Total Liab. & Tot. Equity | $421,875,000 | $346,175,000 | $2,330,916 | $2,258,082 |
| Net Debt | -$26,938,000 | -$78,716,000 | $11,108,220 | $20,800,515 |